Sensura to Showcase Non-Invasive Health Monitoring Platform, Starting with Glucose, at CES 2026

Core Insights - Sensura, a Singapore-based deep-tech company, is set to showcase its non-invasive health monitoring platform for glucose at CES 2026 in Las Vegas [1][5] Group 1: Product Features - The glucose monitoring platform includes two device form factors: a handheld device for quick spot checks and a wearable device for continuous monitoring [2] - The handheld prototype is suitable for both clinical and home use, allowing for rapid, non-invasive measurements [3] - The wearable prototype provides continuous, real-time glucose trend insights, helping users understand the impact of diet and lifestyle on metabolic health [3][4] Group 2: Technology and Innovation - Sensura's platform utilizes proprietary optical sensing technology, custom chip architecture, and AI-driven analytics to facilitate non-invasive monitoring [4][7] - The non-invasive approach aims to reduce user burden associated with traditional glucose monitoring methods, which often involve invasive sensors and frequent replacements [4] Group 3: Strategic Goals and Partnerships - CES 2026 marks a significant milestone for Sensura as it transitions from prototype development to validation and strategic partnerships [5] - The company plans to engage with global healthcare leaders and technology partners during CES and the upcoming J.P. Morgan Healthcare Conference [6]